Healthcare -
Medical - Healthcare Information Services - NASDAQ - US
$ 1.95
-1.01 %
$ 60.8 M
Market Cap
-16.42
P/E
1. INTRINSIC VALUE
Balance Sheet
Forian Inc.
| Current Assets | 44.5 M |
| Cash & Short-Term Investments | 35.1 M |
| Receivables | 6.56 M |
| Other Current Assets | 2.82 M |
| Non-Current Assets | 2.71 M |
| Long-Term Investments | 0 |
| PP&E | 82.2 K |
| Other Non-Current Assets | 2.63 M |
| Current Liabilities | 16.6 M |
| Accounts Payable | 983 K |
| Short-Term Debt | 6.72 M |
| Other Current Liabilities | 8.9 M |
| Non-Current Liabilities | 728 K |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 728 K |
EFFICIENCY
Earnings Waterfall
Forian Inc.
| Revenue | 20.2 M |
| Cost Of Revenue | 7.33 M |
| Gross Profit | 12.8 M |
| Operating Expenses | 19.8 M |
| Operating Income | -6.99 M |
| Other Expenses | -3.22 M |
| Net Income | -3.77 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Forian Inc.
| Net Income | -3.77 M |
| Depreciation & Amortization | 85.4 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 6.53 M |
| Change in Working Capital | 417 K |
| Others | -2.59 M |
| Free Cash Flow | 283 K |
Wall Street Analysts Price Targets
Forian Inc.
FORA has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
FORA does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Forian Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
112 K USD 1
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Forian Partners With Databricks to Expand Access to Advanced Healthcare Analytics
NEWTOWN, Pa., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced a partnership with Databricks, the data and AI company, to deliver access to its Chartis™ product, which maps physician and organization affiliations, through Databricks Marketplace. This collaboration will empower healthcare organizations with enhanced visibility into Forian's robust information products, driving innovative solutions in healthcare research, drug development and patient care.
globenewswire.com
- 5 months ago
Forian Inc. (FORA) Q3 2024 Earnings Call Transcript
Forian Inc. (NASDAQ:FORA ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Max Wygod - Executive Chairman and CEO Michael Vesey - CFO Conference Call Participants Richard Baldry - ROTH Capital Operator Greetings, and welcome to Forian Inc. Third Quarter 2024 Financial Results Conference Call and Webcast. At this time, all participants are in a listen only mode.
seekingalpha.com
- 6 months ago
Forian Inc. (FORA) Surpasses Q3 Earnings Estimates
Forian Inc. (FORA) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.03 per share a year ago.
zacks.com
- 6 months ago
Forian Inc. Announces Third Quarter 2024 Financial Results
NEWTOWN, Pa., Nov. 13, 2024 (GLOBE NEWSWIRE) -- NEWTOWN, Pa. Forian Inc. (Nasdaq: FORA), a leading provider of data science driven information and analytics solutions to the life science, healthcare and financial services industries, today announced results for the quarter ended September 30, 2024.
globenewswire.com
- 6 months ago
VerticalScope Sets New Record for Monthly Active Users, Fueling Double-digit Revenue Growth and Strong Cash Flow in the Third Quarter of 2024
TORONTO--(BUSINESS WIRE)---- $FORA #VerticalScope--VerticalScope Holdings Inc. (“VerticalScope” or the “Company”) (TSX: FORA; OTCQX: VFORF), a technology company that has built and operates a cloud-based digital platform for online enthusiast communities, today announced financial results for the third quarter ended September 30, 2024 ("Q3" or "the quarter"). “Our team delivered another strong quarter in Q3 with momentum building in the business as we enter our strongest seasonal period to end the year,” said Rob Laidl.
businesswire.com
- 6 months ago
Forian Inc. to Participate in the 13th Annual ROTH MKM Technology Event
NEWTOWN, Pa., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA) announces that Max Wygod, Chief Executive Officer and Executive Chairman, and Mike Vesey, Chief Financial Officer, will attend ROTH MKM's 13th annual Technology Event, which will be held on November 19th – 20th, 2024, at the Hard Rock Hotel in New York City.
globenewswire.com
- 6 months ago
Forian Inc. to Announce Third Quarter 2024 Results on November 13, 2024
NEWTOWN, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its third quarter 2024 financial results on Wednesday, November 13, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on November 13, 2024 to discuss the results.
globenewswire.com
- 6 months ago
Forian Acquires Kyber Data Science to Enhance Data Analytics Capabilities
NEWTOWN, PA, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced it has acquired Kyber Data Science LLC (“Kyber”), a trusted provider of advanced healthcare data analytics and machine learning solutions to the financial services industry, from TD Cowen. This strategic acquisition strengthens Forian's position in the healthcare information marketplace through the addition of advanced analytics and software capabilities and expands the industries Forian serves to include financial services.
globenewswire.com
- 6 months ago
VerticalScope to Announce Third Quarter 2024 Results
TORONTO--(BUSINESS WIRE)---- $FORA #earnings--VerticalScope Holdings Inc. ("VerticalScope" or the “Company”) (TSX: FORA; OTCQX: VFORF) announced today that the Company's third quarter 2024 financial results will be released after the market close on Tuesday, November 12, 2024. Management will host a conference call and webcast to discuss the Company's financial results at 8:00 a.m. ET on Wednesday, November 13, 2024. Live Call Registration and Webcast: https://events.q4inc.com/attendee/861368726 Joining Live by Te.
businesswire.com
- 7 months ago
VerticalScope Refinances Its Existing Senior Secured Credit Facility
TORONTO--(BUSINESS WIRE)---- $FORA--VerticalScope Holdings Inc. (“VerticalScope” or the “Company”) (TSX: FORA; OTCQX: VFORF) announced today that it had entered into a second amended and restated credit agreement (such agreement, the “A&R Credit Agreement”), amending and restating the Company's existing credit agreement with Capital One (the “Existing Credit Agreement”). The A&R Credit Agreement was amended and restated to remove the single term loan tranche under the Existing Credit Agreement an.
businesswire.com
- 7 months ago
Forian Inc. (FORA) Q2 2024 Earnings Call Transcript
Forian Inc. (NASDAQ:FORA ) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Max Wygod - Executive Chairman and CEO Michael Vesey - CFO Conference Call Participants Richard Baldry - ROTH Capital Partners Operator Greetings, and welcome to Forian's Second Quarter 2024 Financial Results Conference Call and Webcast. At this time, all participants are in listen-only mode.
seekingalpha.com
- 9 months ago
Forian Inc. (FORA) Reports Q2 Loss, Misses Revenue Estimates
Forian Inc. (FORA) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of $0.03. This compares to loss of $0.03 per share a year ago.
zacks.com
- 9 months ago
8. Profile
Summary
Forian Inc. FORA
COUNTRY
US
INDUSTRY
Medical - Healthcare Information Services
MARKET CAP
$ 60.8 M
Dividend Yield
0.00%
Description
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
Contact
41 University Drive, Newtown, PA, 18940
https://forian.com
IPO
Date
March 3, 2021
Employees
47
Officers
Mr. Max C. Wygod
Co-Founder, Chief Executive Officer, President & Executive Chairman of the Board
Mr. Edward Francis Spaniel Jr.
Executive Vice President, General Counsel & Secretary
Mr. Jason Holden
Vice President of Corporate Development
Mr. Paul Reuscher
Chief Commercial Officer
Mr. Jeff Forringer
President of Kyber Data Science
Mr. Adam H. Dublin
Co-Founder, Chief Strategy Officer & Director